Eton Pharmaceuticals, Inc. Amortization of Debt Discount (Premium)
Eton Pharmaceuticals, Inc. (ETON) reported Amortization of Debt Discount (Premium) of $278.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2026-06-30 was $160.00K, a 233.33% increase year-over-year.
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2026-03-31 was $118.00K, a 59.86% decline year-over-year.
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $175.00K, a 83.16% decline year-over-year.
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $189.00K, a 551.72% increase year-over-year.
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2025 was $696.00K, a 37.24% decline from fiscal 2024.
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2024 was $1.11M, a 847.86% increase from fiscal 2023.
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2023 was $117.00K, a 7.87% decline from fiscal 2022.
- Eton Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2022 was $127.00K, a 14.19% decline from fiscal 2021.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 3 month as first filed | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $278.00K 10-Q · filed 2026-08-13 | $453.00K derived: sum of 3 quarters · filed 2026-08-13 | $642.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $118.00K 10-Q · filed 2026-05-14 | $293.00K derived: sum of 2 quarters · filed 2026-05-14 | $482.00K derived: sum of 3 quarters · filed 2026-05-14 | $530.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $364.00K derived: sum of 2 quarters · filed 2026-03-19 | $412.00K derived: sum of 3 quarters · filed 2026-08-13 | $696.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $189.00K 10-Q · filed 2025-11-06 | $237.00K derived: sum of 2 quarters · filed 2026-08-13 | $521.00K 10-Q · filed 2025-11-06 | $1.57M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $342.00K 10-Q · filed 2026-08-13 | $1.38M derived: sum of 3 quarters · filed 2026-08-13 | $1.41M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $294.00K 10-Q · filed 2026-05-14 | $1.33M derived: sum of 2 quarters · filed 2026-05-14 | $1.36M derived: sum of 3 quarters · filed 2026-05-14 | $1.39M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.07M derived: sum of 2 quarters · filed 2026-03-19 | $1.09M derived: sum of 3 quarters · filed 2026-03-19 | $1.11M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $29.00K 10-Q · filed 2025-11-06 | $22.00K 10-Q · filed 2024-11-12 | $52.00K derived: sum of 2 quarters · filed 2025-11-06 | $70.00K 10-Q · filed 2025-11-06 | $104.00K derived: sum of 4 quarters · filed 2026-03-19 |
| 2024-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $48.00K 10-Q · filed 2025-08-07 | $75.00K derived: sum of 3 quarters · filed 2026-03-19 | $104.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-03-31 | $25.00K 10-Q · filed 2025-05-13 | $52.00K derived: sum of 2 quarters · filed 2026-03-19 | $81.00K derived: sum of 3 quarters · filed 2026-03-19 | $113.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2023-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $56.00K derived: sum of 2 quarters · filed 2026-03-19 | $88.00K derived: sum of 3 quarters · filed 2026-03-19 | $117.00K 10-K · filed 2026-03-19 | |
| 2023-09-30 | $29.00K 10-Q · filed 2024-11-12 | $61.00K derived: sum of 2 quarters · filed 2024-11-12 | $90.00K 10-Q · filed 2024-11-12 | $121.00K derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $61.00K 10-Q · filed 2024-08-08 | $92.00K derived: sum of 3 quarters · filed 2025-03-18 | $182.00K derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-03-31 | $29.00K 10-Q · filed 2024-05-09 | $60.00K derived: sum of 2 quarters · filed 2025-03-18 | $150.00K derived: sum of 3 quarters · filed 2025-03-18 | $180.00K derived: sum of 4 quarters · filed 2025-03-18 | |
| 2022-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $121.00K derived: sum of 2 quarters · filed 2025-03-18 | $151.00K derived: sum of 3 quarters · filed 2025-03-18 | $127.00K 10-K · filed 2025-03-18 | |
| 2022-09-30 | $90.00K 10-Q · filed 2023-11-09 | $120.00K derived: sum of 2 quarters · filed 2023-11-09 | $96.00K 10-Q · filed 2023-11-09 | $194.00K derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $66.00K 10-Q · filed 2023-08-10 | $104.00K derived: sum of 3 quarters · filed 2024-03-14 | $141.00K derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-03-31 | $36.00K 10-Q · filed 2023-05-11 | $74.00K derived: sum of 2 quarters · filed 2024-03-14 | $111.00K derived: sum of 3 quarters · filed 2024-03-14 | $148.00K derived: sum of 4 quarters · filed 2024-03-14 | |
| 2021-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $75.00K derived: sum of 2 quarters · filed 2024-03-14 | $112.00K derived: sum of 3 quarters · filed 2024-03-14 | $148.00K 10-K · filed 2024-03-14 | |
| 2021-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $74.00K derived: sum of 2 quarters · filed 2022-11-10 | $110.00K 10-Q · filed 2022-11-10 | $146.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $73.00K 10-Q · filed 2022-08-11 | $109.00K derived: sum of 3 quarters · filed 2023-03-16 | $144.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-03-31 | $36.00K 10-Q · filed 2022-05-12 | $72.00K derived: sum of 2 quarters · filed 2023-03-16 | $107.00K derived: sum of 3 quarters · filed 2023-03-16 | $130.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2020-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $71.00K derived: sum of 2 quarters · filed 2023-03-16 | $94.00K derived: sum of 3 quarters · filed 2023-03-16 | $121.00K 10-K · filed 2023-03-16 | |
| 2020-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-16 | $58.00K derived: sum of 2 quarters · filed 2021-11-16 | $85.00K 10-Q · filed 2021-11-16 | ||
| 2020-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $50.00K 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $27.00K 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | $16.00K 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |